Evidence map›Paper›PMID 24928618›Full record

ArticleBrain research2014

TLR signaling controls lethal encephalitis in WNV-infected brain.

Amir H Sabouri, Maria Cecilia Garibaldi Marcondes, Claudia Flynn, Michael Berger, Nengming Xiao, Howard S Fox, Nora E Sarvetnick

Abstract read
In one paragraph

Article in Brain research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Depletion of Microglia in anMicrobiology spectrum · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amir H SabouriDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Maria Cecilia Garibaldi MarcondesMolecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA 92037, United States. Electronic address: cmarcond@scripps.edu.
Claudia FlynnDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Michael BergerGenetics Department, The Scripps Research Institute, La Jolla, CA, United States.
Nengming XiaoGenetics Department, The Scripps Research Institute, La Jolla, CA, United States.
Howard S FoxMolecular and Cellular Neuroscience Department, The Scripps Research Institute, La Jolla, CA 92037, United States.
Nora E SarvetnickDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, United States.
Scripps Research Institute · US

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
Molecular Aspects of CNS Dysfunction Due to SIV/HIVR01MH073490 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S · 2005 to 2014
$3.9M
Methamphetamine and Immune Cells in NeuroAIDSR21DA029491 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARCONDES, MARIA CECILIA GARIBALDI · 2011 to 2012
$521k
Free Radicals and Methamphetamine AbuseR03DA027936 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI MARCONDES, MARIA CECILIA GARIBALDI · 2009 to 2010
$94k
NIAID NIH HHS U54 AI065359NIAID NIH HHS U54AI065359NIDA NIH HHS R03 DA027936NIDA NIH HHS R21 DA029491NIDA NIH HHS R21DA029491NIMH NIH HHS P30 MH062261NIMH NIH HHS R01 MH073490
6 · The paper itself

Abstract

Toll-like receptors (TLRs) are known to be activated in Central Nervous System (CNS) viral infections and are recognized to be a critical component in innate immunity. Several reports state a role for particular TLRs in various CNS viral infections. However, excessive TLR activation was previously reported by us in correlation with a pathogenic, rather than a protective, outcome, in a model of SIV encephalitis. Here we aimed at understanding the impact of TLR-mediated pathways by evaluating the early course of pathogenesis in the total absence of TLR signaling during CNS viral infections. We utilized a mouse model of sublethal West Nile virus (WNV) infection. WNV is an emerging neurotropic flavivirus, and a significant global cause of viral encephalitis. The virus was peripherally injected into animals that simultaneously lacked two key adapter molecules of TLR signaling, MyD88 and TRIF. On day 2 pi (post infection), MyD88/Trif-/- mice showed an increased susceptibility to WNV infection, and revealed an impairment in innate immune cytokines, when compared to wild type mice (WT). By day 6 pi, there was an increase in viral burden and robust expression of inflammatory cytokines as well as higher cell infiltration into the CNS in MyD88/Trif-/-, when compared to infected WT. A drastic increase in microglia activation, astrogliosis, and inflammatory trafficking were also observed on day 6 pi in MyD88/Trif-/-. Our observations show a protective role for TLR signaling pathways in preventing lethal encephalitis at early stages of WNV infection.

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsBrainCell LineCricetinaeDisease ProgressionMaleMembrane GlycoproteinsMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88RNA, ViralSignal TransductionSurvival AnalysisToll-Like Receptor 3Toll-Like Receptor 4Adaptor Proteins, Vesicular TransportMembrane GlycoproteinsMyd88 protein, mouseMyeloid Differentiation Factor 88RNA, ViralTicam1 protein, mouseTLR3 protein, mouseTlr4 protein, mouseTlr7 protein, mouseTlr9 protein, mouseToll-Like Receptor 3Toll-Like Receptor 4Toll-Like Receptor 7Toll-Like Receptor 9Toll-Like ReceptorsMyD88Toll-like receptors (TLRs)TrifWest Nile Virus

Identifiers

PMID24928618
PMCPMC4099315
OpenAlexW2154176943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.